Top Companies in the Intracranial Aneurysm Market & Their Offerings
| Companies | Headquarter | Offerings |
| Strayer Corporation | Michigan, U.S. | Flow diverters, detachable coils, stents, and neurovascular embolization devices |
| Medtronic | Dublin, Ireland | Flow diversion systems, embolization coils, and endovascular treatment devices |
| MicroPort Scientific Corporation | Shanghai, China | Coil embolization systems and neurovascular intervention devices |
| Johnson & Johnson | New Jersey, U.S. | Neurovascular stents, embolization systems, and aneurysm treatment solutions |
| Terumo Corporation | Tokyo, Japan | Microcatheters, guidewires, and aneurysm flow disruption devices |
| Penumbra, Inc | California, U.S. | Catheter-based neurovascular access and embolization solution |
What are the Recent Developments in the Intracranial Aneurysm Market?
- In January 2026, Boston Scientific signed a definitive agreement to acquire Penumbra, Inc., aiming to strengthen its footprint in cardiovascular and neurovascular care. The acquisition is expected to expand its offerings in high-growth vascular treatment areas, particularly mechanical thrombectomy and advanced neurovascular intervention technologies, further reinforcing its position in the intracranial aneurysm and stroke care market.
- In July 2025, RSNA introduced the Intracranial Aneurysm Detection AI Challenge to speed up innovation in AI-based radiology tools and improve patient outcomes. Conducted in collaboration with leading neuroradiology and neurointerventional societies, the initiative focuses on enhancing AI-driven detection and precise localization of intracranial aneurysms using imaging techniques such as CTA, MRA, and MRI.
Supply Chain Analysis
Clinical Trials
- Clinical trials in the intracranial aneurysm market mainly focus on assessing the safety and performance of advanced endovascular devices, especially flow diverters and coiling systems. Research is also aimed at improving treatment outcomes for both ruptured and unruptured aneurysms, along with better blood pressure control strategies to reduce complications and recurrence risk.
- Key players: Stryker, Medtronic, Terumo, Penumbra, Johnson & Johnson, MicroPort Scientific.
R&D
- Research and development in the intracranial aneurysm is advancing quickly, with a strong focus on minimally invasive endovascular solutions, AI-enabled diagnostic technologies, and personalized treatment approaches. Companies are investing in smarter imaging systems, next-generation flow diversion devices, and targeted therapies to improve patient outcomes.
- Key players: Stryker, Medtronic, Terumo, Penumbra, MicroPort Scientific, Balt, Acandis.
Patient Support and Services
- Patient support and services cover the entire care journey, from early diagnosis and specialized treatment to post-procedure monitoring and long-term rehabilitation. The focus is on improving recovery, managing neurological and cognitive complications, and enhancing quality of life.
- Key players: Stryker, Medtronic, Johnson & Johnson, Terumo, Penumbra, MicroPort Scientific.
Market Growth
The global intracranial aneurysm market size was estimated at USD 2.45 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 5.64 billion by 2035, expanding at a CAGR of 8.7% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking